“…Metabolic syndrome and its components are recognized as an important risk factor for cryptogenic cirrhosis. [1] Studies from India have shown that, in cases of unexplained elevation of liver enzymes, cryptogenic cirrhosis or cryptogenic hepatocellular carcinoma, NAFLD is an important etiological factor. [2] NAFLD is seen in 9% to 12% of the general population and have higher prevalence of obesity, overweight, prediabetes , diabetes and metabolic syndrome , majority of these patients were also noted to have insulin resistance.…”